An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two ...

The FDA approved Gleevec in 2001. Now, 25 years later, millions of leukemia patients around the world who faced a death ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting ...

Scientists have uncovered dementia-like behavior in pancreas cells at risk of turning into cancer. The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a ...

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...

Mayo Clinic announced a newly developed artificial intelligence model can help specialists detect pancreatic cancer up to three years earlier than previously possible.

The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to ...

On World Ovarian Cancer Day, doctors urge women to dismiss dangerous myths delaying diagnosis. Persistent, mild symptoms like bloating and abdominal discomfort, not severe pain, are key warnings.